These findings correlated with current literature about TOP2A expression and cancer prognosis; TOP2A expression was already described as an independent predictor of an unfavorable prognosis in sarcomas in a study conducted by Da Cunha et al. in 2012. This evidence concerns the gene TOP2A and sarcoma.